CSE:AYUR

Ayurcann Commences Trading on The CSE

Ayurcann Holdings Corp. (CSE: AYUR) ("Ayurcann" or the "Company"), an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to announce that the Company will commence trading at market open today on the Canadian Securities Exchange (the "CSE") under the symbol "AYUR".

Ayurcann is a market leader within the cannabis extraction business and has created a turn-key post-harvest outsourcing solution for licensed cannabis producers. The Company concentrates on the post-harvest requirements of licensed cannabis producers and other brands looking to enter the cannabis market, and offers end-to-end full outsourcing solutions including extraction, refinement, formulation, packaging, fulfillment and distribution. The Company holds a Processing Licence and a Research Licence issued by Health Canada, and operates primarily out of its facility in Pickering, Ontario, which provides it with easy access to licensed producers and other cannabis market participants in the region.

Igal Sudman, Chief Executive Officer of the Company said, "I am so grateful for our loyal shareholders, strategic stakeholders and the many people who have supported us along in our journey to get to this point. As a public company, we believe that our enhanced profile will improve our access to capital, potential acquisition opportunities, and will vastly accelerate our development in becoming the largest go-to provider of cannabis extraction services in Canada."

"This year has been wild in the capital markets and we can see that investors are now looking to deploy their capital into real operating companies. Ayurcann has experienced significant revenue growth YoY and we plan for further double-digit growth in 2021. Our time to shine is right now, and we are excited to showcase our bright future as a listed company on the CSE," said Roman Buzaker, President and Chief Operating Officer of the Company.

For additional information, please contact:

Ayurcann Holdings Corp.
Igal Sudman, Chairman, Chief Executive Officer and Corporate Secretary
905.492.3322 x 301
igal@xtrx.ca
www.ayurcann.com

Investor Relations:
Ryan Bilodeau
Tel: 416-910-1440
Email: IR@ayurcann.com

Neither the CSE nor its regulation services provider accepts responsibility for the adequacy or accuracy of this release.

Certain statements included in this press release constitute forward-looking information or statements (collectively, "forward-looking statements"), including those identified by the expressions "anticipate", "believe", "plan", "estimate", "expect", "intend", "may", "should" and similar expressions to the extent they relate to the Company or its management. The forward- looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements, including: listing of the common shares of the Company on the CSE. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.

Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include failure to obtain regulatory approval, the continued availability of capital and financing, and general economic, market or business conditions. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the statements will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company's forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/79794

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Ayurcann

Ayurcann

Toll Processing & White Label Solutions for Licensed Producers

Toll Processing & White Label Solutions for Licensed Producers Keep Reading...
Cannabis plant with green leaves and buds on a dark green background.

Cannabis Market Forecast: Top Trends for Cannabis in 2026

The US cannabis market is entering 2026 with brighter prospects after a punishing few years marked by stalled rescheduling efforts, price compression, retail saturation and slow state expansion.Now, however, regulatory tailwinds seeming aligned for a potential re-rating.On December 18, US... Keep Reading...
Cannabis plant in focus, blurred US flag background.

Analysts React: Trump Signs Executive Order to Reschedule Cannabis

The long-debated issue of US cannabis rescheduling is finally back in the spotlight. On Thursday (December 18), President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now... Keep Reading...
Close-up of green cannabis leaves in natural light.

Trump Weighs Executive Order to Loosen Federal Cannabis Restrictions

US President Donald Trump is reportedly weighing a major shift in federal drug policy that would relax decades-old restrictions on cannabis, potentially injecting new life into the industry. Six people familiar with the discussions told the Washington Post that Trump is preparing an executive... Keep Reading...
Gavel on a surface with scattered cannabis leaves, symbolizing legal issues around marijuana.

Hemp THC Recriminalization: A Blow to a Blooming Industry

A spending bill to reopen the US government after a 43 day shutdown includes provisions that will recriminalize most hemp-derived THC products. This change, slated to become effective one year after enactment, in late 2026, marks a significant policy reversal from the 2018 Farm Bill, which... Keep Reading...
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...

Interactive Chart

Latest Press Releases

Related News